SY

Synergy Innovation Co., Ltd.

Biotech firm developing drugs, medical devices & microbial culture media for hospitals & industry.

048870 | KO

Overview

Corporate Details

ISIN(s):
KR7048870000
LEI:
Country:
South Korea
Address:
경기도 성남시 중원구 사기막골로 52 5층(상대원동, 선텍시티2), 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Synergy Innovation Co., Ltd. is a technology-driven company focused on the biotechnology sector, which it is nurturing as a new growth engine. The company engages in research, development, and investment across various fields, including generic and new drugs, medical devices, genetics, and health functional foods. A key area of specialization includes providing innovative microbial culture media solutions for both hospitals and industrial applications. The company actively pursues growth through both internal R&D and external investments in the bio-business space.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-08-07 00:00
M&A Activity
주요사항보고서(타법인주식및출자증권양도결정)
Korean 22.1 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-04-17 00:00
Share Issue/Capital Change
전환청구권행사
Korean 10.7 KB
2025-04-16 00:00
Share Issue/Capital Change
전환청구권행사
Korean 10.3 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.3 KB
2025-03-21 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 2.7 MB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.7 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 657.0 KB
2025-03-13 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.4 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.9 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.9 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 1.4 MB
2025-02-24 00:00
Share Issue/Capital Change
전환가액의조정
Korean 12.0 KB

Automate Your Workflow. Get a real-time feed of all Synergy Innovation Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Synergy Innovation Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Synergy Innovation Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.